[go: up one dir, main page]

ES2081783T1 - Alcaloides procedentes de mappia foetida, uso de estos y formulaciones que los contienen. - Google Patents

Alcaloides procedentes de mappia foetida, uso de estos y formulaciones que los contienen.

Info

Publication number
ES2081783T1
ES2081783T1 ES94110864T ES94110864T ES2081783T1 ES 2081783 T1 ES2081783 T1 ES 2081783T1 ES 94110864 T ES94110864 T ES 94110864T ES 94110864 T ES94110864 T ES 94110864T ES 2081783 T1 ES2081783 T1 ES 2081783T1
Authority
ES
Spain
Prior art keywords
alcaloids
formulations containing
water
mappia
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES94110864T
Other languages
English (en)
Other versions
ES2081783T3 (es
Inventor
Ezio Bombardelli
Giuseppe Mustich
Luisella Verotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Publication of ES2081783T1 publication Critical patent/ES2081783T1/es
Application granted granted Critical
Publication of ES2081783T3 publication Critical patent/ES2081783T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G5/00—Alkaloids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS ALCALOIDES OBTENIDOS DE LA MAPPIA FOETIDIA, FOETIDINA 1 Y 2, QUE TIENE PROPIEDADES ANTICANCERIGENAS Y ANTIVIRALES. ESTOS ALCALOIDES, SOLUBLES EN AGUA, SE ENCUENTRAN PRESENTES EN TODAS LAS PARTES DE LA PLANTA Y SON LOS PRECURSORES DE LA CAMPTOTECINA Y DE LA 9-METOXICAMPTOTECINA QUE SON ALCALOIDES QUE SE SABE POSEEN PROPIEDADES FARMACODINAMICAS PERO QUE TAMBIEN SON INSOLUBLES EN AGUA. EL PARTICULAR SOLUBILIDAD EN AGUA DE LOS NUEVOS COMPUESTOS HACE QUE SEAN PARTICULARMENTE ADECUADOS PARA TRATAR A PACIENTES POR VIA PARENTERAL, CON LO QUE SE EVITA EL USO DE EXCIPIENTES TOXICOS O DE DERIVADOS QUIMICOS NO ADECUADOS.
ES94110864T 1994-05-30 1994-07-13 Alcaloides de mappia foetida, su uso y formulaciones que los contienen. Expired - Lifetime ES2081783T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941112A IT1269862B (it) 1994-05-30 1994-05-30 Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono

Publications (2)

Publication Number Publication Date
ES2081783T1 true ES2081783T1 (es) 1996-03-16
ES2081783T3 ES2081783T3 (es) 1997-12-16

Family

ID=11369016

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94110864T Expired - Lifetime ES2081783T3 (es) 1994-05-30 1994-07-13 Alcaloides de mappia foetida, su uso y formulaciones que los contienen.

Country Status (20)

Country Link
US (1) US5525609A (es)
EP (1) EP0685481B1 (es)
JP (1) JP3615240B2 (es)
KR (1) KR0149723B1 (es)
CN (1) CN1052233C (es)
AT (1) ATE159527T1 (es)
CA (1) CA2127763C (es)
CZ (1) CZ290320B6 (es)
DE (2) DE69406430T2 (es)
DK (1) DK0685481T3 (es)
ES (1) ES2081783T3 (es)
FI (1) FI106202B (es)
GR (2) GR960300006T1 (es)
HK (1) HK1003833A1 (es)
HU (1) HU216844B (es)
IT (1) IT1269862B (es)
NO (1) NO179640C (es)
PL (1) PL177042B1 (es)
RU (1) RU2123005C1 (es)
SK (1) SK279615B6 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527913A (en) * 1993-02-25 1996-06-18 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
WO1996011005A2 (en) * 1994-10-06 1996-04-18 Atlas Leon T Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
IT1283635B1 (it) * 1996-05-10 1998-04-23 Indena Spa Composti a scheletro camptotecinico isolati da mappia foetida e loro uso come sintoni per farmaci o come principi attivi
FR2792937B1 (fr) 1999-04-27 2001-08-10 Cemaf NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT
AUPQ987400A0 (en) * 2000-09-04 2000-09-28 Food Ingredients Technologies Intangibles (Bermuda) Limited Process for selectively extracting bioactive components
AU2003265223A1 (en) * 2002-03-01 2003-12-22 University Of Pittsburgh Mappicine analogs, methods of inhibiting retroviral reverse transcriptase and methods of treating retroviruses
US6893668B2 (en) * 2003-03-31 2005-05-17 Council Of Scientific And Industrial Research Process for isolation of anticancer agent camptothecin from Nothapodytes foetida
US20060135546A1 (en) * 2004-12-16 2006-06-22 Jagadevappa Basavaraja Methods for the purification of 20(S)- camptothecin
CN103181272A (zh) * 2011-12-28 2013-07-03 广东神农衍生物科技有限公司 一种药用原材料臭马比木的人工种植方法
CN104619322B (zh) * 2013-07-24 2016-10-19 张苑金 抗癌药物组合物及其制备方法和用途
CN105053041A (zh) * 2015-08-11 2015-11-18 长沙秋点兵信息科技有限公司 一种用于农作物的杀虫剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332413C (en) * 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS6461482A (en) * 1987-08-31 1989-03-08 Yakult Honsha Kk Dehydrocamptothecin and production thereof
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
JP2795460B2 (ja) * 1988-06-20 1998-09-10 協和醗酵工業株式会社 ピラゾロアクリドン誘導体
IL94600A0 (en) * 1989-06-06 1991-04-15 Rhone Poulenc Sante Pyridobenzoindole compounds,their preparation and compositions containing them
ATE136898T1 (de) * 1991-10-29 1996-05-15 Glaxo Wellcome Inc Wasserlösliche camptothecinderivate
CA2087898A1 (en) * 1992-01-24 1993-07-25 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
AP9300587A0 (en) * 1992-11-12 1995-05-05 Glaxo Inc Water soluble camptothecin derivatives.
US5352789A (en) * 1993-02-25 1994-10-04 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds

Also Published As

Publication number Publication date
EP0685481A2 (en) 1995-12-06
ATE159527T1 (de) 1997-11-15
JPH07330772A (ja) 1995-12-19
NO179640B (no) 1996-08-12
RU94026100A (ru) 1996-05-27
SK279615B6 (sk) 1999-01-11
HU9402089D0 (en) 1994-09-28
ES2081783T3 (es) 1997-12-16
ITMI941112A0 (it) 1994-05-30
KR950032253A (ko) 1995-12-20
NO942633L (no) 1995-12-01
CA2127763A1 (en) 1995-12-01
JP3615240B2 (ja) 2005-02-02
PL304577A1 (en) 1995-12-11
FI943294L (fi) 1995-12-01
NO179640C (no) 1996-11-20
GR960300006T1 (en) 1996-02-29
US5525609A (en) 1996-06-11
HU216844B (hu) 1999-09-28
IT1269862B (it) 1997-04-15
FI943294A0 (fi) 1994-07-11
DE69406430T2 (de) 1998-02-26
DK0685481T3 (da) 1998-05-25
CN1052233C (zh) 2000-05-10
EP0685481B1 (en) 1997-10-22
SK83494A3 (en) 1995-12-06
CZ290320B6 (cs) 2002-07-17
HK1003833A1 (en) 1998-11-06
CA2127763C (en) 1997-02-25
PL177042B1 (pl) 1999-09-30
NO942633D0 (no) 1994-07-13
RU2123005C1 (ru) 1998-12-10
EP0685481A3 (en) 1996-03-06
HUT71510A (en) 1995-12-28
DE69406430D1 (de) 1997-11-27
CZ171894A3 (en) 1995-12-13
GR3025120T3 (en) 1998-01-30
KR0149723B1 (ko) 1998-08-17
CN1121075A (zh) 1996-04-24
ITMI941112A1 (it) 1995-11-30
FI106202B (fi) 2000-12-15
DE685481T1 (de) 1996-10-10

Similar Documents

Publication Publication Date Title
ES2079694T3 (es) Derivados de bifenilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
AR023574A1 (es) Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
ES2094721T3 (es) Analogos de la camptotecina solubles en agua.
AR005053A1 (es) Compuestos de difenilhexano, un procedimiento para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos, y procedmientos para la manufactura de medicamentos para inhibir la infeccion de hiv
ES2196377T3 (es) Derivados de naftiridina.
BR9915822A (pt) Derivados de pirazolopirimidinona para o tratamento de impotência
ES2081783T1 (es) Alcaloides procedentes de mappia foetida, uso de estos y formulaciones que los contienen.
ES2093979T3 (es) Esteres nitricos de derivados del acido 2-(2,6-dihalofenilamino)fenilacetico y su procedimiento de preparacion.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
ES2062943B1 (es) Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
BR9407711A (pt) Composto de ciclopeptídeo processo para preparaçao de um composto de ciclopeptídeo e parasiticida
ES2129485T3 (es) Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
ES2072881T3 (es) Procedimiento de preparacion de glicoconjugados de fosforamida mostaza e isofosforamida mostaza.
ES2100335T3 (es) Derivados de benzopirano y fenol para empleo como agentes inmunoestimulantes.
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
ES2195158T3 (es) Amidas de alfa-aminoacidos, su preparacion y el uso terapeutico de las mismas.
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
ES2074508T3 (es) Benzocicloalquilaminopiridinaminas y compuestos afines, un procedimiento e intermediarios para su preparacion y su uso como medicamentos.
MX9401295A (es) Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen.
MX9300840A (es) Compuestos farmaceuticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
PE26691A1 (es) Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas
ES2036545T3 (es) Derivados de n-1h-tetrazol-5-il-(anillo de 5 eslabones)-carboxamida, un procedimiento para su preparacion y el uso de los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 685481

Country of ref document: ES